One unique finding was an imbalance in diabetic retinopathy complications in SUSTAIN-6: 3.0% of semaglutide patients vs 1.8% of placebo had retinopathy progression ( [133] )
What GLP-1 Does in Your Body Your intestinal L-cells secrete GLP-1 in response to food, particularly when you eat carbohydrates, fats, and proteins
Animal models have demonstrated how SFN can alter microbiota composition, correlating with behavioral improvements, and suggest that targeting gut bacteria may be one of the mechanisms of benefit
The mainstream pharmaceutical approach, exemplified by tirzepatide and bremelanotide, emphasizes rigorous FDA approval pathways, large-scale randomized controlled trials, and treatment of specific age-related diseases ( In contrast, the longevity medicine approach, prevalent in anti-aging clinics and compounding pharmacy networks, views aging itself as a modifiable process amenable to intervention ( A third perspective emerges from Russian gerontological research, which has developed and clinically used peptides such as epitalon and Semax for decades with apparent success ( 7.2 Controversies and safety considerations The peptide landscape in gerontology is fraught with controversy
Medical Questionnaire (Required) After purchase, complete a detailed questionnaire